Atlas Trials

Prednisone Administration in Quiescent COPD Patients to Determine the Effect on Gene Expression

Clinical trial NCT02534402 · UNKNOWN

Trial details

NCT number
NCT02534402
Sponsor
University of British Columbia
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Obstructive Pulmonary Disease
Start date
2015-08-01
Primary completion
2016-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.